Table 1.
Type of Study | [6-OHDA] | Treatment | Modified Parameters in SNpc DAergic Neuron | Molecular Mechanisms |
Reference |
---|---|---|---|---|---|
Ex vivo, rat | 0.2, 0.5, 1, 2 (mM) | 5 or 10 min | Inhibition of spontaneous firing; Rm drop; Ca2+ accumulation | D2-GIRK and KATP channels activation; mitochondrial release of Ca2+ ions | [23] |
Ex vivo, rat | 0.5, 1, 2 (mM) | 3–5 min | Inhibition of spontaneous firing; Ca2+ accumulation | N-type VGCC current amplitude increase | [24] |
In vitro organotypic culture, rat | 25 µM | 12 or 18 h | Irregular firing/bursting; depolarized RMP | Increased AHP and IAHP mediated by SK channels | [25] |
In vivo, mouse | 1.5 µg/µL (1.6 µL) | 1 injection, SNpc | 1 to 8 weeks after lesion; Lack of maturation of Rm, AP half-width, steady-state I(-100mV) | [26] | |
In vivo, rat | 4 µg/4 µL | 1 injection, MFB; tested 16–20 days after lesion | Increase in firing rate, n. of bursting neurons and n. spikes/burst | Release of glutamate and mGluR activation (rescue by MPEP) | [27] |
In vivo, rat | 4 µg/2 µL | 1 injection, MFB, 4–6 weeks after lesion | Decreased n. of active neurons; no significant difference in firing rate nor bursting; higher CV | Rearrangements of circuitry to compensate for neuronal loss | [28] |
In vivo, rat | 8 µg/4 µL | 1 injection, MFB | 32 days after lesion, 76% reduction in firing rate | Excessive GABA release by reactive astrocytes, rescued by MAO inhibitor safinamide | [7] |
Ex vivo | Ipsilateral slices from in vivo lesioned rat | Increase tonic GABAA current; no difference in sIPSC amplitude or frequency | Rescued by bicuculline and safinamide | [7] |